A review for the clinician: classifications, genetics, and treatment for neuroendocrine neoplasms of the thymus (thymic carcinoids)
Background: Thymic carcinoids or neuroendocrine neoplasms (t-NEN) are a rare entity with a dismal prognosis. About 25% of the tumors are related to multiple endocrine neoplasia type I (MEN-1), where they contribute significantly to mortality. The tumors are classified according to the WHO classifica...
Gespeichert in:
| Hauptverfasser: | , , , , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
December 2025
|
| In: |
Neuroendocrinology
Year: 2025, Jahrgang: 115, Heft: 12, Pages: 957-968 |
| ISSN: | 1423-0194 |
| DOI: | 10.1159/000544982 |
| Online-Zugang: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1159/000544982
|
| Verfasserangaben: | Matthias Lang, Chrysanthi Anamaterou, Isabelle Mohr, Mária Černá, Manuel Röhrich, Christine Tjaden |
MARC
| LEADER | 00000naa a22000002c 4500 | ||
|---|---|---|---|
| 001 | 1960479652 | ||
| 003 | DE-627 | ||
| 005 | 20260210085528.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 260210s2025 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1159/000544982 |2 doi | |
| 035 | |a (DE-627)1960479652 | ||
| 035 | |a (DE-599)KXP1960479652 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Lang, Matthias |d 1967- |e VerfasserIn |0 (DE-588)122237625 |0 (DE-627)705824888 |0 (DE-576)293166722 |4 aut | |
| 245 | 1 | 2 | |a A review for the clinician |b classifications, genetics, and treatment for neuroendocrine neoplasms of the thymus (thymic carcinoids) |c Matthias Lang, Chrysanthi Anamaterou, Isabelle Mohr, Mária Černá, Manuel Röhrich, Christine Tjaden |
| 264 | 1 | |c December 2025 | |
| 300 | |a 12 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Veröffentlicht: 11. März 2025 | ||
| 500 | |a Gesehen am 10.02.2026 | ||
| 520 | |a Background: Thymic carcinoids or neuroendocrine neoplasms (t-NEN) are a rare entity with a dismal prognosis. About 25% of the tumors are related to multiple endocrine neoplasia type I (MEN-1), where they contribute significantly to mortality. The tumors are classified according to the WHO classification, TNM classification and Masaoka-Koga staging system, although none of the classifications have been developed for t-NEN. A recently proposed t-NEN specific morphomolecular classification is based on copy number instability scores. Its role is yet to be defined. The prognosis depends on resectability, histological features, metastasis, the amount of copy number instabilities and mitotic activity. Summary: No study-based therapies exist. The mainstay of therapy is surgical resection as it is associated with significantly improved long-term survival. Based on published cases and small series, for non-resectable and recurring disease, platinum-based chemotherapies are preferred in neuroendocrine carcinoma, while everolimus and temozolomide are recommended in thymic neuroendocrine tumors. Key Messages: This review covers current classification systems and the knowledge of genetic disorders and medical therapies. | ||
| 700 | 1 | |a Anamaterou, Chrysanthi |e VerfasserIn |4 aut | |
| 700 | 1 | |a Mohr, Isabelle |d 1989- |e VerfasserIn |0 (DE-588)1188592181 |0 (DE-627)1667540092 |4 aut | |
| 700 | 1 | |a Černá, Mária |e VerfasserIn |4 aut | |
| 700 | 1 | |a Röhrich, Manuel |e VerfasserIn |4 aut | |
| 700 | 1 | |a Tjaden, Christine |e VerfasserIn |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Neuroendocrinology |d Basel : Karger, 1965 |g 115(2025), 12 vom: Dez., Seite 957-968 |h Online-Ressource |w (DE-627)30059478X |w (DE-600)1483028-0 |w (DE-576)273877690 |x 1423-0194 |7 nnas |a A review for the clinician classifications, genetics, and treatment for neuroendocrine neoplasms of the thymus (thymic carcinoids) |
| 773 | 1 | 8 | |g volume:115 |g year:2025 |g number:12 |g month:12 |g pages:957-968 |g extent:12 |a A review for the clinician classifications, genetics, and treatment for neuroendocrine neoplasms of the thymus (thymic carcinoids) |
| 856 | 4 | 0 | |u https://doi.org/10.1159/000544982 |x Verlag |x Resolving-System |z lizenzpflichtig |3 Volltext |7 1 |
| 951 | |a AR | ||
| 992 | |a 20260210 | ||
| 993 | |a Article | ||
| 994 | |a 2025 | ||
| 998 | |g 1188592181 |a Mohr, Isabelle |m 1188592181:Mohr, Isabelle |d 910000 |d 910100 |e 910000PM1188592181 |e 910100PM1188592181 |k 0/910000/ |k 1/910000/910100/ |p 3 | ||
| 998 | |g 122237625 |a Lang, Matthias |m 122237625:Lang, Matthias |d 910000 |d 910100 |e 910000PL122237625 |e 910100PL122237625 |k 0/910000/ |k 1/910000/910100/ |p 1 |x j | ||
| 999 | |a KXP-PPN1960479652 |e 4912219398 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"origin":[{"dateIssuedDisp":"December 2025","dateIssuedKey":"2025"}],"name":{"displayForm":["Matthias Lang, Chrysanthi Anamaterou, Isabelle Mohr, Mária Černá, Manuel Röhrich, Christine Tjaden"]},"recId":"1960479652","person":[{"role":"aut","family":"Lang","given":"Matthias","display":"Lang, Matthias"},{"family":"Anamaterou","given":"Chrysanthi","display":"Anamaterou, Chrysanthi","role":"aut"},{"family":"Mohr","given":"Isabelle","display":"Mohr, Isabelle","role":"aut"},{"given":"Mária","display":"Černá, Mária","family":"Černá","role":"aut"},{"display":"Röhrich, Manuel","given":"Manuel","family":"Röhrich","role":"aut"},{"role":"aut","display":"Tjaden, Christine","given":"Christine","family":"Tjaden"}],"title":[{"title_sort":"review for the clinician","subtitle":"classifications, genetics, and treatment for neuroendocrine neoplasms of the thymus (thymic carcinoids)","title":"A review for the clinician"}],"language":["eng"],"id":{"doi":["10.1159/000544982"],"eki":["1960479652"]},"type":{"media":"Online-Ressource","bibl":"article-journal"},"physDesc":[{"extent":"12 S."}],"note":["Veröffentlicht: 11. März 2025","Gesehen am 10.02.2026"],"relHost":[{"pubHistory":["1.1965/66 -"],"type":{"bibl":"periodical","media":"Online-Ressource"},"recId":"30059478X","disp":"A review for the clinician classifications, genetics, and treatment for neuroendocrine neoplasms of the thymus (thymic carcinoids)Neuroendocrinology","language":["eng"],"physDesc":[{"extent":"Online-Ressource"}],"id":{"issn":["1423-0194"],"zdb":["1483028-0"],"eki":["30059478X"]},"part":{"issue":"12","extent":"12","pages":"957-968","year":"2025","volume":"115","text":"115(2025), 12 vom: Dez., Seite 957-968"},"note":["Gesehen am 09.01.2019"],"origin":[{"publisherPlace":"Basel","dateIssuedKey":"1965","dateIssuedDisp":"1965-","publisher":"Karger"}],"title":[{"title":"Neuroendocrinology","subtitle":"international journal for basic and clinical studies on neuroendocrine relationships ; official organ of the International Society of Neuroendocrinology","title_sort":"Neuroendocrinology"}]}]} | ||
| SRT | |a LANGMATTHIREVIEWFORT2025 | ||